Search Results

FDNA Inc, the leader in the early detection of rare genetic diseases, and Genome Medical, the nation’s leading telehealth provider of genetic services, have partnered to empower parents to detect potential developmental, neurological and genetic conditions in their children and connect with specialists quickly – a move that may shorten the diagnostic odyssey for children from an average of five years to a few months.

FDNA, the leader for the early detection of rare genetic diseases, announced today that its breakthrough study findings were published in the esteemed peer-reviewed journal Nature Genetics, in a paper titled “GestaltMatcher facilitates rare disease matching using facial phenotype descriptors.”

FDNA, a leader in artificial intelligence and precision medicine, in collaboration with a team of influential scientists and researchers published a milestone study on the use of facial analysis in detecting genetic disorders.

FDNA, in collaboration with The Focus Foundation, announces the successful recognition of the facial phenotype of 49,XXXXY (“49ers”) syndrome.

FDNA today announces the launch of the Genomics Collaborative along with multiple medical research collaborations as part of a new global initiative.

FDNA, developer of the Face2Gene suite of next-generation phenotyping (NGP) applications, announces at the American College of Medical Genetics and Genomics annual meeting the appointment of Dr. Karen Gripp to Chief Medical Officer and Dr. Peter Krawitz to Chief Data Science Officer.

Together, they will offer genomic services paired with next-generation phenotyping technologies for more efficient and accurate diagnoses.